Pure Global

Aspire Syphilis Rapid test - Taiwan Registration a4c17cb0b9105925c5161da8cf0e1321

Access comprehensive regulatory information for Aspire Syphilis Rapid test in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a4c17cb0b9105925c5161da8cf0e1321 and manufactured by FIRSTEP BIORESEARCH INC.. The authorized representative in Taiwan is FIRSTEP BIORESEARCH INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
a4c17cb0b9105925c5161da8cf0e1321
Registration Details
Taiwan FDA Registration: a4c17cb0b9105925c5161da8cf0e1321
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Aspire Syphilis Rapid test
TW: ๅฎ‰้€Ÿ็™พ็ˆพๆข…ๆฏ’่žบๆ—‹้ซ”ๆŠ—้ซ”่ฉฆๅŠ‘
Risk Class 2
MD

Registration Details

a4c17cb0b9105925c5161da8cf0e1321

Ministry of Health Medical Device Manufacturing No. 005358

Company Information

Taiwan, Province of China

Product Details

This reagent is used by immunochromatography to qualitatively detect antibodies in human serum, plasma or whole blood against Treponema pallidum, a bacterium that causes syphilis infection. This test can be used to assist in the detection of treponemal antibodies in infected individuals.

C Immunology and microbiology devices

C3830 Treponema pallidum reagent

Produced in Taiwan, China

Dates and Status

Dec 14, 2016

Dec 14, 2026